---
title: "Delayed ART initiation and low nadir CD4 count linked to worse mood in adults with chronic HIV"
id: "medrxiv-19-delay-in-antiretroviral-therapy-initiation-is-associated-with-worse-mood"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-19-delay-in-antiretroviral-therapy-initiation-is-associated-with-worse-mood"
content_type: "clinical_feed_article"
specialty: "Infectious Disease"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.10.07.26364968v1?rss=1"
published_at: "2026-10-08T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Delayed ART initiation and low nadir CD4 count linked to worse mood in adults with chronic HIV
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-19-delay-in-antiretroviral-therapy-initiation-is-associated-with-worse-mood
- **Specialty:** [Infectious Disease](https://medichelpline.com/clinical-feed/infectious-disease.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.10.07.26364968v1?rss=1)
- **Published At:** 2026-10-08T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- This cross-sectional preprint compared 109 people with HIV (PWH) with 42 demographically matched people without HIV (PWoH) to evaluate mood symptoms and cognitive function. - Participants were middle-aged adults (mean age 55.6 years) with long HIV disease duration (mean 24.6 ± 9.3 years) and diverse demographics: 62.9% African American and 27.2% female; mean education 14.3 ± 2.9 years. - Mood was assessed using the **Beck Depression Inventory-II (BDI-II)** and the **Profile of Mood States (POMS)**; cognitive performance was measured with a comprehensive neuropsychological battery. - Despite largely similar neurocognitive test results, PWH had significantly worse mood: higher total **BDI-II** (p < .001) and higher total **POMS** (p = .002), and worse scores across most POMS subscales (all p < .007) except Vigor (p = .724). - Within the PWH group, longer delays in initiating **antiretroviral therapy (ART)**, lower **nadir CD4** counts, and lower educational attainment were associated with worse mood symptoms. - Current plasma CD4 count, detectable plasma viral load, and overall HIV disease duration were not associated with BDI-II or POMS scores in this sample. - Authors conclude that mood disturbance remains prevalent among PWH on ART and that the long-term legacy effects of delayed ART initiation and low nadir CD4 reinforce the clinical importance of early ART initiation. - This work is a medRxiv preprint (not peer reviewed); IRB approval was obtained from Georgetown University Medical Center and deidentified data are available on request. Funder information includes NIH grants reported in the source.
## Clinical Analysis & Structured Key Points
Delay in antiretroviral therapy initiation is associated with worse mood symptoms in adults with chronic HIV disease | medRxiv Skip to main content Delay in antiretroviral therapy initiation is associated with worse mood symptoms in adults with chronic HIV disease View ORCID Profile Hyunchan Lee , Claire O'Connor , Grace Hanly , Linxi Chen , Danial Mahmood , David J. Moore , Ronald J. Ellis , View ORCID Profile Xiong Jiang doi: https://doi.org/10.64898/2026.10.07.26364968 Hyunchan Lee 1 Georgetown University Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Hyunchan Lee For correspondence: dr.hyunchan{at}gmail.com Claire O'Connor 1 Georgetown University Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Grace Hanly 1 Georgetown University Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Linxi Chen 1 Georgetown University Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Danial Mahmood 1 Georgetown University Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site David J. Moore 2 University of California San Diego; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Ronald J. Ellis 3 University of California, San Diego Find this author on Google Scholar Find this author on PubMed Search for this author on this site Xiong Jiang 1 Georgetown University Medical Center; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Xiong Jiang Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract Background. In the era of successful antiretroviral therapy (ART), mood disturbance remains highly prevalent in people with HIV (PWH). In the present study, we investigated the long-term legacy effects of long delay in ART initiation and low nadir CD4 count on mood symptoms in adults with HIV. The impacts of demographic and other HIV clinical factors were also examined. Methods. A total of 109 PWH (disease duration: 24.6±9.3 years) and 42 demographically matched healthy participants (people without HIV, or PWoH) participated in a cross-sectional study (41-70 years old (55.6±6.8), 62.9% African Americans, 27.2% female, 14.3±2.9 years of education). Mood symptoms were assessed with the Beck Depression Inventory-II (BDI-II) and the Profile of Mood States (POMS). A comprehensive neuropsychological test battery was administered to assess neurocognitive function. Results. Despite largely comparable neurocognitive performance between PWH and PWoH , PWH had worse mood symptoms than PWoH, including higher total BDI-II (p<.001) and total POMS scores (p=.002), as well as higher score in all POMS sub-scores (p<.007), except Vigor (p=.724). Within the PWH group, longer delays in ART initiation, lower nadir CD4 count, and lower educational attainment were associated with worse mood symptoms. By contrast, current plasma CD4+ cell count, plasma detectable viral load, and HIV disease duration were not associated with either BDI-II or POMS score. Conclusion. Mood disturbance is highly prevalent in PWH on ART. The long-term legacy effects of delay in ART initiation and low nadir CD4 count on mood management reinforce the necessity of early ART initiation in clinical practice. Competing Interest Statement The authors have declared no competing interest. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Institutional Review Board of Georgetown University Medical Center gave ethical approval for this work. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability To protect patients′ privacy, deidentified data are available upon reasonable request. Funder Information Declared National Institutes of Health, https://ror.org/01cwqze88 , R01MH108466 , R56NS124422 , R01NS124422 , R56AG089864 , R01AG089864-01A1 , P30MH062512 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license . Back to top Previous Next Posted October 08, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Delay in antiretroviral therapy initiation is associated with worse mood symptoms in adults with chronic HIV disease Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Delay in antiretroviral therapy initiation is associated with worse mood symptoms in adults with chronic HIV disease Hyunchan Lee , Claire O'Connor , Grace Hanly , Linxi Chen , Danial Mahmood , David J. Moore , Ronald J. Ellis , Xiong Jiang medRxiv 2026.10.07.26364968; doi: https://doi.org/10.64898/2026.10.07.26364968 Share This Article: Copy Citation Tools Delay in antiretroviral therapy initiation is associated with worse mood symptoms in adults with chronic HIV disease Hyunchan Lee , Claire O'Connor , Grace Hanly , Linxi Chen , Danial Mahmood , David J. Moore , Ronald J. Ellis , Xiong Jiang medRxiv 2026.10.07.26364968; doi: https://doi.org/10.64898/2026.10.07.26364968 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area HIV/AIDS Subject Areas All Articles Addiction Medicine (626) Allergy and Immunology (914) Anesthesia (341) Cardiovascular Medicine (4892) Dentistry and Oral Medicine (486) Dermatology (421) Emergency Medicine (661) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1649) Epidemiology (16084) Forensic Medicine (34) Gastroenterology (1221) Genetic and Genomic Medicine (7136) Geriatric Medicine (739) Health Economics (1077) Health Informatics (5147) Health Policy (1448) Health Systems and Quality Improvement (1798) Hematology (593) HIV/AIDS (1357) Infectious Diseases (except HIV/AIDS) (16372) Intensive Care and Critical Care Medicine (1185) Medical Education (681) Medical Ethics (156) Nephrology (729) Neurology (7410) Nursing (371) Nutrition (1105) Obstetrics and Gynecology (1268) Occupational and Environmental Health (1013) Oncology (3668) Ophthalmology (1071) Orthopedics (399) Otolaryngology (460) Pain Medicine (485) Palliative Medicine (142) Pathology (713) Pediatrics (1824) Pharmacology and Therapeutics (741) Primary Care Research (777) Psychiatry and Clinical Psychology (6007) Public and Global Health (9853) Radiology and Imaging (2470) Rehabilitation Medicine and Physical Therapy (1482) Respiratory Medicine (1257) Rheumatology (653) Sexual and Reproductive Health (788) Sports Medicine (589) Surgery (788) Toxicology (107) Transplantation (311) Urology (299)
## Related Clinical Research

- [Multimorbidity with tuberculosis in Kampala: prevalence, care gaps and impact on outcomes](https://medichelpline.com/clinical-feed/medrxiv-1-multimorbidity-in-tuberculosis-and-its-impact-on-health-and-treatment-outcomes.md)
- [ADHD trait screening in adults with HIV and PrEP users in Switzerland: study protocol](https://medichelpline.com/clinical-feed/medrxiv-10-screening-for-attention-deficit-hyperactivity-disorder-traits-among-adults.md)
- [Semaglutide plus menopause hormone therapy linked to greater weight loss in midlife women](https://medichelpline.com/clinical-feed/medical-news-today-0-ozempic-plus-hormone-therapy-may-help-boost-weight-loss-at-menopause.md)
- [ADHD and dementia risk: new study links ADHD to later-life cognitive impairment](https://medichelpline.com/clinical-feed/medical-news-today-1-is-adhd-a-risk-factor-for-dementia-new-research-suggests-it-might-be.md)
- [PMOS (formerly PCOS): Renaming Spurs Hope for Better Awareness and Diagnosis in Black and Latina W](https://medichelpline.com/clinical-feed/stat-news-4-after-pcos-became-pmos-there-s-hope-for-new-awareness-among-black-and-latina.md)

## Navigation
- [← Back to Infectious Disease Feed](https://medichelpline.com/clinical-feed/infectious-disease.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.